Viewing Study NCT04025450


Ignite Creation Date: 2025-12-24 @ 5:21 PM
Ignite Modification Date: 2026-01-02 @ 3:42 AM
Study NCT ID: NCT04025450
Status: RECRUITING
Last Update Posted: 2019-07-19
First Post: 2019-07-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients
Sponsor: The First Affiliated Hospital of Soochow University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module